These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 4319729
1. Aluminum-marker of wild type 1 poliovirus strains. Nakao C, Tagaya I, Komatsu T, Kodama H. Jpn J Microbiol; 1970 Sep; 14(5):405-12. PubMed ID: 4319729 [No Abstract] [Full Text] [Related]
2. Investigation of some possibilities of producing type 3 vaccine poliovirus with greater genetic stability. I. Preliminary experiments with passage variants. Elbert LB, Chumakov MP, Krutyanskaya GL, Ralph NM, Tyufanov AV. Acta Virol; 1968 May; 12(3):193-202. PubMed ID: 4385148 [No Abstract] [Full Text] [Related]
3. Studies on the mutagenic action of proflavine on type 3 poliovirus. Pervikov YV, Vorohsilova MK, Chumakov MP, Savinov AP, Yurovetskaya AL. Acta Virol; 1973 Jul; 17(4):365. PubMed ID: 4148222 [No Abstract] [Full Text] [Related]
4. Studies on characteristics of poliovirus. 3. Investigation of d, rct, h and n markers of poliovirus isolated after vaccination with the Type 1, Chat strain. Böttiger M. Arch Gesamte Virusforsch; 1966 Jul; 18(2):135-54. PubMed ID: 4293025 [No Abstract] [Full Text] [Related]
5. Behavior of poliovirus strains of different virulence under solid overlays. Balayan MS, Voroshilova MK, Sinyak LI, Chumakova AB. Arch Gesamte Virusforsch; 1970 Jul; 32(4):299-310. PubMed ID: 4322846 [No Abstract] [Full Text] [Related]
6. Serodifferentiation of poliovirus strains. II. Modified Wecker test on type 3 poliovirus strains. Soda K, Kitahara T, Nakao C, Hara M, Tagaya I. Jpn J Med Sci Biol; 1969 Aug; 22(4):201-16. PubMed ID: 4311582 [No Abstract] [Full Text] [Related]
7. Studies on characteristics of poliovirus. II. Plaque-forming capacity of attenuated poliovirus strains in human and monkey kidney cell cultures. Böttiger M. Arch Gesamte Virusforsch; 1966 Aug; 18(2):127-34. PubMed ID: 4293024 [No Abstract] [Full Text] [Related]
8. Investigation of type 3 poliovirus variants with increased L-cystine-dependence as live vaccines. Elbert LB, Chumakov MP, Krutyanskaya GL, Ralph NM, Tyufanov AV, Sokolova IS, Alpatova GA. Arch Gesamte Virusforsch; 1971 Aug; 33(3):259-70. PubMed ID: 4329636 [No Abstract] [Full Text] [Related]
16. [Agar culture of kidney cells of green African marmosets and the cytopathic effect]. Levi MI. Vopr Virusol; 1969 Aug; 14(1):111-4. PubMed ID: 4307613 [No Abstract] [Full Text] [Related]
17. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINE. III. IS THERE INTERFERENCE BY SV 40 AGAINST POLIOVIRUS?]. GUENTHER O, VON METTENHEIM, HOEVEL H. Zentralbl Bakteriol Orig; 1964 Feb; 192():1-11. PubMed ID: 14176847 [No Abstract] [Full Text] [Related]
18. Neurovirulence of polioviruses isolated from sewage and stool of healthy children. I. Studies on neurovirulence, antigenic marker and RCT-40 mrker of type 2 strains. Wilterdink JB, Smit GL, Verlinde JD. Arch Gesamte Virusforsch; 1969 Feb; 28(1):68-76. PubMed ID: 4315814 [No Abstract] [Full Text] [Related]
19. [The intratypical differentiation of strains of the poliovirus group (marker determination)]. Kuwert E. Arch Hyg Bakteriol; 1966 Sep; 150(5):447-59. PubMed ID: 4295632 [No Abstract] [Full Text] [Related]
20. Evolution of poliovirus since introduction of attenuated vaccine. Cossart YE. Br Med J; 1977 Jun 25; 1(6077):1621-3. PubMed ID: 194650 [Abstract] [Full Text] [Related] Page: [Next] [New Search]